Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. [electronic resource]
Producer: 20130710Description: 113-9 p. digitalISSN:- 1876-4479
- Adalimumab
- Adolescent
- Adult
- Age Factors
- Analysis of Variance
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Colitis, Ulcerative -- diagnosis
- Crohn Disease -- diagnosis
- DNA, Viral -- blood
- Female
- Hepacivirus -- immunology
- Hepatitis B Antibodies -- blood
- Hepatitis B Surface Antigens -- blood
- Hepatitis B Vaccines
- Hepatitis B virus -- immunology
- Hepatitis B, Chronic -- epidemiology
- Hepatitis C Antibodies -- blood
- Hepatitis C, Chronic -- epidemiology
- Humans
- Infliximab
- Male
- Middle Aged
- Prevalence
- RNA, Viral -- blood
- ROC Curve
- Time Factors
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.